trial · primary record
No intervention
Angelman Syndrome
| Phase | Phase 2 |
|---|---|
| Status | TERMINATED |
| Sponsor | Unknown |
| Enrolment | 55 |
| Primary completion | 2026-10-30 |
| Primary endpoint | Subprotocol A/B/C/D: Number of Participants with Treatment Emergent Adverse Events (TEAEs) and Serious Adverse Events (SAEs), Severe Events, and Events Related to Investigational Product, Procedure, and Premedication |
| Registry ID | NCT07157254 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:40.808Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07157254
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.